Inspire Pharmaceuticals ISPH
-
Specialty biopharmaceutical company Auxilium Pharmaceuticals ([[AUXL]] +4.9%) says its CEO and President Armando Anido has agreed to step down and resign. Adrian Adams, most recently chairman and CEO ...
… biotechnology firm Neurologix, has been appointed in his place. Adams has more than 30 years of experience in the pharmaceutical industry, and led Inspire Pharmaceuticals in its strategic acquisition by Merck. Post your comment!
-
17 Stocks Under $5 Being Chased by Big Money Managers
Kapitall submits: If you’re interested in low-cost stocks, looking at the institutional interest of those names can be a great guide. We searched among stocks trading under $5 for those who have seen the greatest buying interest from institutional investors, measured by shares purchased as a ...
-
Cramer's Mad Money - 6 Earnings and IPOs to Watch for the Coming Week (4/8/11)
Miriam Metzinger submits: Stocks discussed on the in-depth session of Jim Cramer's Mad Money TV Program, Friday April 8. 6 Earnings and IPOs to Watch in the Upcoming Week: Alcoa ( AA ), JPMorgan ( JPM ), Bank of America ( BAC ), Google ( GOOG ), Zipcar ( ZIP ), Arcos Dorados Holdings ( ARCO ); ...
-
Fred Hassan Isn't the Only Serial Seller in the Pharma Industry
… you to - or remind you of the existence of - Adrian Adams. Earlier this week, he notched a deal to sell Inspire Pharmaceuticals ( ISPH ), where he is CEO, to Merck for $430 million, or $5 a share, a 26 percent premium at the time of the …
-
Merck to acquire Inspire Pharma for $430 million
CHICAGO (Reuters) - Merck & Co said on Tuesday it would acquire eye treatment maker Inspire Pharmaceuticals Inc for about $430 million to expand its ophthalmology business.
-
Merck to acquire Inspire Pharma for $430 million
CHICAGO (Reuters) - Merck & Co said on Tuesday it would acquire eye treatment maker Inspire Pharmaceuticals Inc for about $430 million to expand its ophthalmology portfolio.
-
Merck ([[MRK]] -0.4%) says it will acquire Inspire Pharmaceuticals ( ISPH ), a developer of ophthalmic products, in an all-cash deal for $5/share, or ~$430M. The offer represents a 26% premium to ...
Merck ( MRK -0.4% ) says it will acquire Inspire Pharmaceuticals ( ISPH ), a developer of ophthalmic products, in an ..... premium to yesterday's closing price. Trading in ISPH halted. ( PR ) Post your comment!
-
UPDATE 1-Inspire drops lung drug, cuts 27 pct jobs
FEB 17 - Inspire Pharmaceuticals Inc said it would drop the development of its cystic fibrosis drug and cut about 27 percent of its workforce related to the drug's development.
-
Short Ideas: 20 Small Cap Stocks With Rising Receivables
Kapitall submits: The following is a list of small cap stocks that short sellers might be interested in. All of these companies have seen accounts receivable grow faster than revenues during the most recent quarter--an accounting trend that deserves closer attention. To create this list, we started
-
Top 16 Most Underestimated Small Cap Stocks
Kapitall submits: The following is a list of small cap stocks, with market caps smaller than $400M. Judging by their earnings results relative to analyst estimates, it's clear that these stocks are being underestimated by analysts. In other words, these companies have a track record of beating ...